Overview

Probiotic and Colchicine in COVID-19

Status:
Completed

Trial end date:
2022-08-30

Target enrollment:

Participant gender:

Summary

Coronavirus disease 2019 (COVID-19) is a newly emerging human disease caused by a novel coronavirus causing a global pandemic crisis. Currently there is no specific treatment for COVID-19, Probiotics and or Colchicine may be considered as an option of treatment since they have anti-viral effect anti-inflammatory and immunomodulatory effect.

Phase:

Phase 1

Details

Lead Sponsor:

Ain Shams University

Treatments:

Colchicine